UnknownNot Applicable

More Air - Better Performance - Faster Recovery

Denmark80 participantsStarted 2021-04-15

Plain-language summary

The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in activities of daily living, endurance in gait, fatigue, voice volume, phonation endurance, and expiratory function. Methods/Design: Randomised controlled trial (RCT) comparing IMT to conventional neurorehabilitation (usual practise). 80 patients, with reduced maximal inspiration pressure (MIP) hospitalized at a specialized neurorehabilitation hospital in Denmark will be included.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * First time brain infarction or brain haemorrhage 0-6 month. * Able to give written consent and being cognitive and communicative able to understand and participate in the maximal inspiration pressure test (MIP) * Reduced MIP below gender and age specific normal standard Exclusion Criteria: * Diagnosis of myocardial infarction within the last 3 months * Significant pulmonary disease (severe COPD), saturation below 90 if having COPD for others saturation below 92 * Neurological deficits other than stroke * Facial palsy that affects proper labial occlusion * Dizziness or nausea/vomiting during MIP-testing.

What they're measuring

Maximal inspiratory pressure (MIP)

Timeframe: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

Trial details

NCT IDNCT04686019

SponsorCentral Jutland Regional Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Hanne Pallesen, Post Doc

004523821365 hannpall@rm.dk